This independent meeting is sponsored by pharmaceutical companies, who have had no influence over, or input into, the meeting agenda or content or selection of speakers, except in the sponsored symposia sessions. Sponsors will not be contributing in any way to any hospitality associated with the meeting. Click here for a list of sponsors.
Join us for our 20th Annual Scientific Meeting where the focus will be on how we can develop multidisciplinary team services in heart and kidney care to meet future needs. This popular one-day meeting will bring together an expert faculty and delegates across the cardiovascular, metabolic and renal teams. State-of-the-art presentations with interactive discussion and case-based learning will be offered, with time to network in the breaks and visit our exhibition.
Is it for me?
Our meetings are aimed at healthcare professionals and are aimed at anyone treating the cardiorenal patient particularly those working in heart failure, cardiology, nephrology, diabetes, lipids, endocrinology, care of the elderly, general medicine, general practice, clinical pharmacy and allied disciplines. Feedback from past delegates has been very positive with 100% of delegates at our last meeting saying the meeting was clinically excellent to good.
Accreditation
The Cardiorenal Forum will award 5 CPD credits for this meeting.
Academic endorsement
This year’s meeting has been endorsed by The British Society for Heart Failure, The Irish Nephrology Society, KDIGO – Kidney Disease Improving Global Outcomes, The UK Kidney Association, and The UK Renal Pharmacy Group.
Registration fee
Our registration fees are subsidised. Registration fees to include lunch and refreshments throughout the day are: £125 doctors (SpR and consultant grades), £90 concessions (nurses, trainees, allied HCPs), £325 commercial organisations. All fees are inclusive of VAT.
Travel grants
Travel grants are now closed.
Meeting location
The meeting is taking place in central London at The King’s Fund, Deans Mews entrance, 11–13 Cavendish Square, London W1G 0AN. A map can be downloaded below.
09:25 | Introduction Chairs: Professor Paul Kalra, Consultant Cardiologist, Portsmouth Hospitals NHS Trust, Portsmouth & Professor Philip Kalra, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester |
09.30 | Future approaches to obesity and diabetes to reduce heart and kidney disease Dr Julia Kenkre, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust, London |
09.50 | The effects of weight loss on cardiometabolic risk - and how to achieve it Dr Elizabeth Morris, General Practitioner and Wellcome Trust Clinical Research Fellow, Nuffield Department of Primary Care Health Sciences, University of Oxford |
10.10 | Discussion |
Chair: Dr Lisa Anderson, Heart Failure Consultant, St George’s University Hospital NHS Foundation Trust; Chair, British Society for Heart Failure | |
10:20 | Device therapy for patients with heart failure Dr Andrew Flett, Consultant Cardiologist, University Hospital Southampton NHS Foundation Trust |
10:40 | Sequencing the re-introduction of heart failure treatment pillars after AKI Ms Victoria Ruszala, Specialist Pharmacist in Cardiology and Heart Failure, North Bristol NHS Trust |
10.55 | Discussion |
11:00 | COFFEE BREAK / EXHIBITION AND NETWORKING |
This is a promotional symposium organised and sponsored by A. Menarini Farmaceutica Internazionale SRL including honoraria in accordance with the ABPI Code of Practice. Intended for UK healthcare professionals only.![]() |
|
The great debate: the high-risk cardiovascular disease patient – who seeks them out and treats them best? Chair: Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester The cardiologist? Professor Julian Halcox, Chair in Cardiology, Swansea University Medical School; Honorary Consultant Cardiologist, Swansea Bay University Health Board The endocrinologist? Professor Vinod Patel, Professor in Clinical Skills, Warwick Medical School, University of Warwick; Honorary Consultant Physician in Endocrinology and Diabetes, George Eliot Hospital NHS Trust, Nuneaton |
Chair: Professor Gerry McCann, NIHR Research Professor, (Experimental Medicine) and Professor of Cardiac Imaging, University of Leicester | |
12:05 | Activity for longevity – truth and reconciliation Professor Thomas Yates, Professor in Physical Health and Activity, Leicester Lifestyle and Health Research Group, Diabetes Research Centre, University of Leicester |
12.25 | Discussion |
Chair: Dr David Lappin, Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway | |
12:30 | Advances in preventing antibody-mediated graft rejection following organ transplantation Dr Ciara Magee, Consultant Nephrologist, Beaumont Hospital, Dublin |
12.55 | Discussion |
13:00 | LUNCH BREAK / EXHIBITION AND NETWORKING |
This is a promotional symposium sponsored and organised by AstraZeneca. Intended for UK healthcare professionals only.![]() |
|
Navigating RAASi roadblocks: a cardio-kidney conversation Dr Sarah Birkhoelzer, Heart Failure and Imaging Fellow, University Hospitals Dorset Professor James Burton, Honorary Consultant Nephrologist and Professor of Renal Medicine at the University of Leicester |
Chairs: Professor Smeeta Sinha, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester & Dr Matthew Graham-Brown, Clinical Associate Professor of Renal Medicine, University of Leicester; Honorary Consultant Nephrologist, University Hospitals of Leicester | |
14:40 | How a bespoke multi-morbidity clinic can improve management of people with metabolic-renal-cardiac-disease Dr Saif Al-Chalabi, Clinical Research Fellow, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust |
14:50 | Lessons from the metabolic-renal-cardiac clinic, e-referrals, and the virtual MDT Professor Darren Green, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Cardiorenal Sciences, Manchester Metropolitan University; Honorary Professor of Medicine, University of Manchester |
15.10 | Discussion |
15:15 | TEA BREAK / EXHIBITION AND NETWORKING |
Chair: Ms Carys Barton, Heart Failure Nurse Consultant, Imperial NHS Foundation Trust, London; Chair-Elect, British Society for Heart Failure & Dr David Mulcahy, Consultant Cardiologist, Blackrock Health Hermitage Clinic, Dublin | |
15:40 | Cardiac trials Dr Geraint Morton, Consultant Cardiologist, Portsmouth Hospitals NHS Trust |
15:55 | Renal trials Dr David Lappin, Consultant Nephrologist, Galway University Hospitals; Honorary Personal Professor of Medicine, University of Galway |
16.10 | Discussion |
Chair: Dr Sarah Birkhoelzer, Heart Failure and Imaging Fellow, University Hospitals Dorset | |
16:15 | Case 1: IgA nephropathy (IgAN) Dr Matthew Graham-Brown, Clinical Associate Professor of Renal Medicine, University of Leicester; Honorary Consultant Nephrologist, University Hospitals of Leicester |
16:30 | Case 2: Cardiac amyloid Ms Angelique Smit, Lead Clinical and Research Nurse, National Amyloidosis Centre, Royal Free London NHS Foundation Trust |
16:45 | Case 3: HIF-PHI Professor Philip Kalra, Consultant Nephrologist, Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust; Professor of Renal Medicine, University of Manchester |
17:00 | Meeting close |
Dr Saif Al-Chalabi |
![]() |
|
Dr Lisa Anderson |
![]() |
|
Mrs Carys Barton |
![]() |
|
Dr Sarah Birkhoelzer |
![]() |
|
Dr Andrew Flett |
![]() |
|
Dr Matthew Graham-Brown |
![]() |
|
Professor Darren Green | ![]() |
|
Professor Paul Kalra |
![]() |
|
Professor Philip Kalra |
![]() |
Dr Julia Kenkre |
![]() |
|
Dr David Lappin |
![]() |
|
Dr Ciara Magee |
![]() |
|
Professor Gerry McCann |
![]() |
|
Dr Elizabeth Morris |
![]() |
|
Dr Geraint Morton |
![]() |
|
Dr David Mulcahy |
![]() |
|
Ms Victoria Ruszala |
![]() |
|
Professor Smeeta Sinha |
![]() |
|
Ms Angelique Smit |
||
Professor Thomas Yates |
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia.
Hansa Biopharma has provided a grant to support travel of a speaker to the meeting.
Medice UK has provided sponsorship towards this event but has had no editorial input into or influence over the agenda, content or the selection of speakers. Medice UK staff are attending and will have a promotional stand at the event.
Novo Nordisk is providing sponsorship for the event but has had no influence over, or input into, the event agenda or content or selection of speakers. Novo Nordisk has been granted stand space and will be present at the conference.
CSL Vifor have supported this meeting by sponsorship in return for stand space, but have had no part in any contents or the agenda of this meeting.